Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Finerenone-related risk of hypotension in patients with heart failure with mildly reduced or preserved ejection fraction

Event: ESC Congress 2025

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Drugs, devices, and diagnostics in heart failure

Access
Like
Thumbnail

Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 3

Access
Like
Thumbnail

Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.

Event: ESC Congress 2018

Topic: Hypertrophic Cardiomyopathy

Session: Atrial fibrillation in hypertrophic cardiomyopathy

Access
Like
Thumbnail

Histopathologic substrates and clinical correlations in type A acute aortic syndromes

Event: ESC Congress 2017

Topic: Aortic Disease

Session: Best Posters in aortic disease

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources